Planview Recognized as a Leader in 2020 Gartner® Magic Quadrant for Enterprise Agile Planning Tools
Planview® today announced it is named a Leader in the 2020 Gartner Magic Quadrant for Enterprise Agile Planning Tools. The report evaluated Planview’s Lean and Agile Delivery solution and positioned the company highest in the Leaders quadrant for Ability to Execute.
“Every organization today has their own transformation story, even Planview. We rewired ourselves to pivot and focus on holistic portfolio and work management solutions, doubling down on Lean and Agile. Core to our vision is to serve enterprises at all stages of Agile transformation, helping them transform on their terms and timeline,” said Patrick Tickle, Planview Chief Product Officer. “We’re excited to be recognized by Gartner.”
According to Gartner, “Enterprise-class agile development is a natural evolution of project-level agile to support the demands of large-scale software management. Agile processes are highly accelerated and iterative. The information needs of agile teams often differ from those of their leadership. This has led to the use of a variety of tools: some for the teams, others for management.”
Planview offers a full spectrum of Portfolio and Work Management solutions that are uniquely positioned to help organizations successfully accelerate on-strategy delivery. With a focus on bringing together leadership solutions spanning Agile and PPM, Planview is the platform partner for enterprise class organizations navigating the transformation of work, portfolio management, and the shift to product-centricity.
“We think Planview’s Leader position shows exactly where Agile is going,” said Dr. Mik Kersten, Tasktop CEO and best-selling author of Project to Product. “Enterprise needs for Agile at scale mean that team-level functionality is no longer enough. It has been amazing to see a leading PPM vendor make such a profound and impactful shift from project to product in their own portfolio, and helping others do the same. As a strategic partner, we are honored to be part of the journey and look forward to Planview driving results in the market at this critical time for organizations needing to shift to software and digital innovation.”
“Working with best-in-class partners like Planview represents our commitment to helping enterprises deliver competitive solutions to its customers in the shortest sustainable lead time,” said Dean Leffingwell, creator of SAFe and co-founder of Scaled Agile, Inc. “Planview’s experience in the Lean Portfolio Management and enterprise Kanban space is an invaluable asset for organizations looking to effectively connect their portfolio to business strategy.”
“When Planview and LeanKit came together in 2017, we shared this vision; it’s why I wanted us to become a part of the Planview family. Our goal from the beginning was to build a Lean and Agile Delivery solution that is pragmatic and reflects the realities of Agile transformation. Transformation takes time, and organizations need a partner that can see and understand the whole journey, even the ugly parts,” explains Jon Terry, former LeanKit co-Founder and current Planview Chief Lean-Agile Evangelist.
To learn more about the Planview Lean and Agile Delivery Solution visit: planview.com/lean-agile-delivery.
Additional Resources:
- Blog: Lean into the Changing World of Work
- Guide: The Ultimate Lean and Agile Software Solution Buyer’s Guide
- Whitepaper: 7 Benefits of Scaling Agile
- 3 Minute Pathfinder: Lean-Agile Pathfinder
Gartner, Magic Quadrant for Enterprise Agile Planning Tools by Keith Mann, Mike West, Bill Blosen, Akis Sklavounakis, Deacon D.K Wan, April 21, 2020
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose
About Planview
Planview has one focus: enabling the transformation journey as organizations rewire strategy to delivery in today’s fast-paced, highly disruptive markets. Our solutions uniquely help organizations navigate this journey and accelerate on-strategy delivery at enterprise scale. Planview’s full spectrum of Portfolio Management and Work Management solutions create organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enable customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, Planview has more than 700 employees supporting 3,500 customers and 1 million users worldwide. For more information, visit https://www.planview.com/.
Planview and LeanKit are registered trademarks of Planview, Inc. and the Planview logo is a trademark of Planview, Inc. All other trademarks are property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200423005753/en/
Contact information
Leslie Marcotte
lmarcotte@planview.com
719-439-4921
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 15:05:00 EET | Press release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 15:03:00 EET | Press release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 15:00:00 EET | Press release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 14:00:00 EET | Press release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 13:30:00 EET | Press release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom